Shamai Carter

Shamai Carter serves as a key procurement lead at the Naval Medical Research Center, supporting the agency’s mission to enhance the operational readiness of U.S. Navy and Marine Corps personnel through advanced biomedical research and field-deployable medical technologies. Responsible for managing complex acquisitions in analytical instrumentation and diagnostic innovation, Carter oversees the procurement of laboratory-grade equipment and rapid diagnostic systems designed for austere environments. Their work directly enables the development and validation of infectious disease detection tools, precision monitoring platforms, and other force health protection solutions critical to expeditionary medical operations. Carter maintains a consistent and strategic partnership with REES SCIENTIFIC CORPORATION, a specialized vendor with deep expertise in analytical laboratory instrumentation and custom diagnostic system integration. This relationship reflects a pattern of long-term, technically demanding engagements focused on high-performance, mission-critical hardware and software solutions. The procurement approach emphasizes technical compliance, performance validation, and adherence to military-grade specifications, indicating a preference for vendors with proven capabilities in ruggedized, deployable medical technologies. Carter’s contracting activity shows a 100% focus on open, unrestricted acquisitions with no use of socioeconomic set-asides such as 8(a), HUBZone, or SDVOSB programs. This reflects a mission-driven prioritization of technical capability and performance over socioeconomic preferences, aligning with the center’s need for specialized, high-reliability equipment that meets stringent operational standards. The primary NAICS classification for Carter’s portfolio is 334516—Analytical Laboratory Instrument Manufacturing—indicating a narrow, high-specialization focus on procuring precision diagnostic instruments, mass spectrometers, PCR platforms, and other laboratory-based analytical systems. Their expertise lies in acquiring next-generation biomedical tools designed for pathogen identification, environmental monitoring, and real-time health surveillance in deployed settings, underscoring a technical domain centered on military medical innovation and diagnostic science.